Equities

Streamline Health Solutions Inc

Streamline Health Solutions Inc

Actions
TechnologyTechnology
  • Price (USD)0.169
  • Today's Change-0.029 / -14.52%
  • Shares traded2.03m
  • 1 Year change-78.88%
  • Beta1.6460
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Streamline Health Solutions, Inc. enables healthcare organizations to proactively address revenue leakage and improve financial performance. The Company delivers integrated solutions, technology-enabled services and analytics. It operates in one segment as a provider of health information technology solutions and associated services that improve healthcare processes and information flows within a healthcare facility. The Company sells its solutions and services in North America to hospitals and health systems through its direct sales force and its reseller partnerships. It offers solutions and services to assist its clients in revenue cycle management, including its two flagship technologies: RevIDTM and eValuatorTM. RevID offers automated, daily reconciliation of clinical event activity to patient billing charge items prior to billing. eValuator provides 100% automated coding analysis prior to billing. It offers an array of professional services, including system implementation.

  • Revenue in USD (TTM)20.30m
  • Net income in USD-18.82m
  • Incorporated1996
  • Employees77.00
  • Location
    Streamline Health Solutions Inc2400 Old Milton Parkway, Box 1353ALPHARETTA 30009United StatesUSA
  • Phone+1 (404) 446-2051
  • Fax+1 (302) 674-5266
  • Websitehttps://www.streamlinehealth.net/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
NewGenIvf Group Ltd0.00-690.85k6.57m----0.1546-----0.1999-0.19990.004.190.00-------1.50---1.54--------------0.0944-------237.99------
Kindly MD Inc3.10m-2.44m7.14m23.00--1.63--2.30-0.4652-0.46520.57430.73760.98675.94471.36134,643.90-77.81---99.26--93.94---78.86--5.36-5.610.0517---0.488--36.34------
Interpace Biosciences Inc41.68m3.00m7.37m108.002.49--2.150.17680.6740.63029.46-2.852.8814.197.10385,888.9020.72-38.19---69.7359.0149.447.19-41.010.46954.95----26.3112.93118.96--0.9184--
Mangoceuticals Inc866.79k-9.13m7.48m----0.5267--8.63-0.4388-0.43880.0410.47470.093519.32-----98.48---107.62--58.19---1,052.90--0.3653-38.860.0134--8,082.22---361.07------
Caremax Inc784.55m-782.86m7.74m1.45k------0.0099-208.41-208.41208.34-38.730.9776--6.10541,069.60-97.55---160.21---3.31---99.78-----1.951.57--19.01---1,707.99------
US NeuroSurgical Holdings Inc0.00-1.02m8.77m2.00--4.39-----0.0928-0.09280.000.14820.00----0.00-45.80-14.62-66.91-19.89-------36.77----0.00------38.97------
Aesthetic Medical Intl Hldg Grp Ltd(ADR)103.07m-6.87m8.98m1.29k--2.274.420.0872-0.1524-0.15242.270.08271.2920.8277.3680,144.66-9.06-23.36-35.45-48.5845.3955.32-7.02-23.720.2031-5.500.9581--1.86-2.1650.91--3.70--
Xcelerate Inc3.96m-296.19k9.21m1.00--6.62--2.33-0.0014-0.00140.01890.00321.516.133.90---11.334.24-49.19--71.7174.10-7.481.930.4797-0.82180.7237--6.6310.4317.00--174.06--
Ontrak Inc12.39m-36.52m10.03m102.00--0.6504--0.8095-2.35-2.350.30570.32130.5173--12.53121,421.60-115.11-54.80-157.11-73.3766.8153.50-222.54-71.95---1.730.3021---12.20-3.4439.08--99.58--
Streamline Health Solutions Inc20.30m-18.82m10.70m77.00--0.673--0.5272-0.3277-0.32770.34990.25110.4397--7.64263,636.40-40.77-22.06-56.63-31.6950.8649.96-92.72-54.55---4.460.4395---9.210.2057-64.31---11.72--
Pacific Health Care Organization Inc6.02m873.35k10.87m30.0012.460.969411.941.810.06820.06820.46930.87630.5208--6.67200,501.307.567.298.107.8178.9782.7514.5213.28----0.00---2.00-3.7055.80-10.80-15.93--
Univec Inc-100.00bn-100.00bn11.86m3.00---------------0.0113-----------50.96------17.47---198.310.0051-------74.07-64.8336.83------
Healthlynked Corp4.06m-4.38m12.12m38.00------2.98-0.0158-0.01590.0148-0.00150.865915.3340.39106,922.10-93.24-119.37-327.73-332.2252.3155.81-107.68-119.260.5622--2.15---2.3220.4357.08---12.94--
Psychemedics Corp.20.79m-4.56m13.63m116.00--2.37--0.6556-0.7882-0.78823.590.98581.57--5.89179,198.30-34.41-7.44-53.29-9.7037.6337.55-21.93-6.26---264.690.1198---12.45-12.33-283.21---33.32--
Data as of Sep 20 2024. Currency figures normalised to Streamline Health Solutions Inc's reporting currency: US Dollar USD

Institutional shareholders

26.24%Per cent of shares held by top holders
HolderShares% Held
Harbert Fund Advisors, Inc.as of 09 Aug 20245.07m8.01%
Tamarack Advisers LPas of 09 Aug 20244.93m7.79%
Perkins Capital Management, Inc.as of 30 Jun 20241.97m3.10%
The Vanguard Group, Inc.as of 30 Jun 20241.66m2.62%
Herald Investment Management Ltd.as of 30 Jun 2024835.46k1.32%
Nicholas Hoffman & Co. LLCas of 30 Jun 2024740.98k1.17%
Geode Capital Management LLCas of 30 Jun 2024479.35k0.76%
BlackRock Fund Advisorsas of 30 Jun 2024373.39k0.59%
Cerity Partners LLCas of 30 Jun 2024290.00k0.46%
Renaissance Technologies LLCas of 30 Jun 2024265.77k0.42%
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.